Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -4.886% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) O=C(NC(Cc1ccccc1)C(=O)NCCc1ccccn1)c1ccccc1
(b) Cc1ccc(-n2nc(C)c(C3(O)C(=O)N(C(C)C)c4ccccc43)c2N)cc1
Answer: b. Cc1ccc(-n2nc(C)c(C3(O)C(=O)N(C(C)C)c4ccccc43)c2N)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2nc(C)c(C3(O)C(=O)N(C(C)C)c4ccccc43)c2N)cc1
Cc1ccc(-n2nc(C)c(C3(O)C(=O)N(C(C)C)c4ccccc43)c2N)cc1
3-[5-amino-3-methyl-1-(4-methylphenyl)pyrazol-4-yl]-3-hydroxy-1-propan-2-ylindol-2-one